Didi Chen

3.2k citations
72 papers · 2.7k · 1 hit paper · h-index 24

Impact in

  • Immunology top 5%
    • interferon and immune responses
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research

Papers in

Didi Chen

68 papers receiving 2.7k citations

Didi Chen's Hit Papers

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing 2017 · 464 citations
4640+3+6Years since publication100200300400

Peers

Didi Chen
Comparison fields: 5 of 112
  • Immunology 544
  • Cancer Research 263
  • Endocrinology 58
  • Cell Biology 142
  • Molecular Biology 649
Replace Barry H. Rickman with:
Barry H. Rickman United States
Mark O. Lively United States
Kelly M. Stewart Canada
Kai Zhang China
Yan Liang China
Jingxin Wang United States
Moreno Zamai Italy
Lingling Wu China
Chenxi He China
Didi Chen relative to Barry H. Rickman United States Barry H. Rickman's profile →
Citations per field
00.5×2×4×6×7.9×
Barry H. Rickman · 1×
Citations per year

Countries citing papers authored by Didi Chen

Since Specialization
Citations

This map shows the geographic impact of Didi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didi Chen more than expected).

Fields of papers citing papers by Didi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didi Chen. The network helps show where Didi Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Didi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Didi Chen Line = papers co-authored together Didi Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015542
2
Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing
Hit paper breakdown →
2017464
3 2014112
4 2010110
5 2015102
6 202098
7 201692
8 201687
9 201571
10 201969
11 202061
12 201554
13 200849
14 201447
15 201543
16 201338
17 201636
18 201633
19 201630
20 201228

About Didi Chen

Didi Chen is a scholar working on Materials Chemistry, Oncology, Cancer Research, Spectroscopy and Immunology, having authored 72 papers that have together received 2.7k indexed citations. Recurring topics across this work include Luminescence and Fluorescent Materials (14 papers), Molecular Sensors and Ion Detection (7 papers), Nanoparticle-Based Drug Delivery (4 papers), Extracellular vesicles in disease (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cellular transport and secretion (3 papers), Phagocytosis and Immune Regulation (3 papers) and Gastrointestinal Tumor Research and Treatment (2 papers). The work is most often cited by research in Immunology (544 citations), Cancer Research (263 citations), Endocrinology (58 citations), Cell Biology (142 citations) and Molecular Biology (649 citations). Didi Chen has collaborated with scholars based in China, United States and Rwanda. Frequent co-authors include Neal M. Alto, Nikolay Burnaevskiy, Nan Yan, Nicole Dobbs, Vijay K. Gonugunta, Yuping Dong, Congying Xie, Xiao Feng, Xiance Jin and Hanbin Chen. Their work appears in journals such as Journal of Materials Chemistry C, Cell Host & Microbe, Sensors and Actuators B Chemical, Journal of Controlled Release and Journal of drug targeting.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact